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Abstract 
   In this study, we have reported a biocompatible metal-organic framework (MOF) with ultra-
high surface area, which we have shown to have uses as both a cancer treatment delivery system 
and for environmental applications. Using a sonochemical approach, highly flexible organic 
H3BTCTB and ditopic 4,4´-BPDC ligands, along with modulators of acetic acid and pyridine 
were combined to prepare a Zn(II)-based metal-organic framework, DUT-32, 
[Zn4O(BPDC)(BTCTB)4/3(DEF)39.7(H2O)11.3]. Powder X-ray diffraction (PXRD), field-emission 
scanning electron microscopy (FE-SEM), and Fourier transform infrared spectroscopy (FTIR) 
were used to characterize, the particle size, shape, and structure of the DUT-32. To show the 
effects of shape and size of DUT-32 micro/nano-structures on doxorubicin (DOX) drug release 
and amoxicillin (AMX) adsorption, time of sonication, initial reagent concentrations, irradiation 
frequency, and acetic acid to pyridine molar ratios were optimized. The drug-loaded DUT-32 
was soaked in simulated body fluid (SBF) and the drug release ratio was monitored through 
release time to perform in vitro drug release test. A slow and sustained release was observed for 
DUT-32 micro/nano-structures, having a considerable drug loading capacity. At the pH values 
7.4-4.5, various profiles of pH-responsive release were achieved. Also, the prepared DUT-32 
micro/nano-structures are found to be biocompatible with PC3 (prostate cancer) and HeLa 
(cervical cancer) cell lines, when tested by MTT assay. Moreover, DUT-32 micro/nano-
structures were studied to show AMX adsorption from aqueous solution. Finally, kinetic studies 
indicated that AMX adsorption and drug release of DOX via this MOF are of first-order kinetics. 
 
Keywords: Metal-organic framework, Modulator, Drug delivery, pH responsive release, 
Doxorubicin, Amoxicillin.  
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1. Introduction 
   As a result of their poor solubility, numerous side effects and non-specificity, many anticancer 
drugs have poor efficiency when it comes to treating the target tumor and often end up severely 
damaging healthy cells throughout the body [1-4]. Therefore, special attention has been paid to 
nano-carriers for drug delivery anticancer therapy, aiming at a targeted release of anticancer 
drugs while keeping the adjacent healthy cells unaffected [5-8]. In this context, porous materials 
have proved to be very successful for drug delivery, possessing advantages such as: high pore 
volume, considerable surface area, and size-adjustable pores [9-14]. Nevertheless, it is a great 
challenge to prepare porous materials in a way that their pore shape and size can be controlled 
[15-17]. 
   From a biomedical perspective, drug release from porous materials is performed in reaction to 
the body’s pH level. This reliance of the drug delivery system on the pH value in the body allows 
for a proper targeted drug delivery, owing to the inhibition of drug release during systemic 
circulation at a physiological pH of 7.4, and hence the drug is only released as it encounters the 
cancerous cells’ acidic environment, leaving neighboring healthy cells unharmed [18-20]. 
Therefore, a proper physiological stimulus for pH-responsive drug delivery can be provided by 
the pH variations in various tissues, organs, and cell parts [21, 22]. As an example, compared to 
the normal tissue and blood, tumorous extracellular microenvironments (pH = 5.7–7.8), 
lysosome (pH = 4.5–5.0) and endosome (pH = 5.5–6.0) compartments are more acidic [23-25]. 
   Recently, medical pollutants (e.g., pollutants caused by the pharmaceutical and personal care 
products) have adversely affected different aqueous media such as groundwater, surficial water, 
wastewater, and even drinking water [26]. In this context, antibiotic organics have attracted 
much attention since they are highly toxic and cannot be easily filtered through sewage filtration 
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equipment and thus threaten the environment [27, 28]. When accumulated in the body, these 
antibiotics can damage the central nervous system, joints, kidneys, etc. [29]. In this study, a 
lactam antibiotic, amoxicillin (AMX), which is common in the treatment of both humans and 
animals, is considered. If 500 mg of AMX is orally administered in humans, then 86 ± 8% 
excretion in the urine is observed in 2 h of consumption since AMX has a slow metabolism rate 
in humans [30-32]. Despite the sensitivity of AMX towards hydrolysis in different pH values 
[33], complete degradation of AMX is difficult as its different hydrolyzed and metabolized by-
products remain present in both urine and feces. Nevertheless, this antibiotic is indigestible, and 
hence it is metabolically dischargeable. AMX is present in both surficial water and secondary 
water drainage at µg L-1 concentrations [34-37]. As a result of its chemical stability, low rate of 
biodegradation and high biological toxicity, it is imperative that research be conducted into 
removal of this persistent organic pollutant (POP) from our water systems. 
  Owing to their significant chemical and physical characteristics (such as record internal surface 
areas, tunable pore size and seemingly limitless functionalisability), metal-organic frameworks 
(MOFs), sometimes referred to as porous coordination polymers (PCPs), have been in the focus 
of scholarly attention worldwide [38-40]. MOFs can consist of a wide range of inorganic metal 
nodes and organic linkers, that serve as hosts for numerous guest molecules, meaning that there 
is seemingly infinite scope for the morphology and chemical functionality of the pores and 
internal surfaces to be systematically tuned and improved [41]. This high degree of tunability 
results in several advantages when it comes to drug loading: It means that theoretically a MOF 
can be developed with the perfect pore size, functionality and guest interactions to both hold and 
release the drug of interest. In addition, MOFs very high specific surface area gives them the 
ability to absorb high quantities of guest molecules [42-46]. Application of nano-MOFs for drug 
  
5 
 
delivery was first proposed by G. Ferey and W.B Lin and other teams [47-50]. As recorded in the 
literature, the MOFs react to the changes of pH, where they can store and release drugs by a 
mechanism of forming and cleaving the coordination bonds, respectively [51]. On the other 
hand, MOFs are outstanding absorption substances since they are very porous and their specific 
surface area is large. 
   The ratio of surface area to volume in nanomaterials is much greater than that of larger 
particles. Thanks to novel synthesis approaches which control the size and morphology of 
micro/nanostructures, the nanostructured coordination compounds such as nano metal-organic 
frameworks have recently been enhanced [52]. Much attention has been paid to the reduction of 
MOF size to micro and nano [53-55]. Different approaches have already been suggested for 
nano-scaled synthesis of MOFs with specific shape [56-58]. Synthetic approaches involving 
ultrasound offer several advantages, including: speed, ease, low cost, ecofriendly and control 
over size and shape of the particles. In sonochemistry, the generating, growing, and collapsing of 
bubbles or ‘acoustic cavitation’ are needed. Somehow this works, is that local hot spots are 
formed which generate high pressures, up to 1000 atm, and temperatures up to 5000 ℃ having 
brief lifetime. As a result of these extraordinary physical characteristics, the synthesis of the 
nanostructures might be furthered, especially through the growth in the crystallization nucleuses 
[59, 60]. To do so, the ultrasonic illumination takes advantage of the acoustic cavitation 
comprising the bubble formation, growth, and implosive collapse in an aqueous solution. One 
protocol for controlling the size and the morphology of MOFs is modulating synthesis. The 
crystal growth can be directed towards desirable particle shape and size if sonochemistry is 
combined with modulating synthesis [61-66]. 
   Using sonochemistry, the present study has sought to optimize the shape and the size of the 
nanostructured DUT-32 particles by varying the ultrasound illumination time and initial reagent 
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concentration in vicinity of the modulator. Also, the particles size and shape effects on the MOFs 
capacity for drug adsorption and drug delivery have been explored. DUT-32 shows excellent 
biocompatibility with two different cell lines. To the best of the authors’ knowledge, this is the 
first attempt to investigate DUT-32 nanostructures for AMX adsorption and drug release of DOX 
(Scheme 1). Our results can be used as a starting point for further investigation of other 
applications, such as the environmental remediation for determinate rule shape and the size the 
nanostructured MOFs for higher efficiency.  
 
 
Scheme 1. Schematic showing DUT-32 absorbing AMX and releasing DOX. 
 
2. Experimental  
2.1. Materials and physical techniques 
All reagents for the synthesis and analysis were commercially available from Merck and Sigma-
Aldrich Companies and used as received. The following chemicals were used in the synthesis 
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procedure: Zinc(II) acetate dihydrate (Zn(CH3COO)2.2H2O 98%, Merck), Zinc nitrate 
hexahydrate (Zn(NO3)2.6H2O 98%, Sigma-Aldrich), and N,N Diethylformamide (DEF 99%, 
Sigma-Aldrich). Water used in the experiments was deionized (DI) and doubly distilled prior to 
use as a washing agent. The ligands of 4,4´-biphenyldicarboxylic acid (4,4´-BPDC) and 4,4´,4´´-
[1,3,5-benzenetriyltris(carbonylimino)]trisbenzoic acid (H3BTCTB) were prepared by the 
reported methods [67, 68]. 
   The shape (or surface morphology), size, and crystal structure of the DUT-32 micro/nano-
structures were characterized by field emission scanning electron microscopy (FE–SEM),  
Powder X–ray diffraction (PXRD), UV–Visible absorption spectroscopy, and Fourier transform 
infrared spectroscopy (FTIR). A Hitachi S–1460 field emission scanning electron microscope at 
an accelerating voltage of 15 kV was employed to obtain the FE–SEM images. For all of the 
samples, PXRD analyses was performed using a Philips diffractometer (Model TM–1800), using 
a nickel filtered Cu–Kα radiation source (λ = 1.542 Å). It uses a proportional counter detector at 
a 4◦/min scan rate, with a scanning angle of 2θ=1°-50° with a 40-kV voltage and a potential 
current of 30 mA. For all samples, the measurement of the UV–Vis absorption spectra was 
carried out in a quartz cell using a Camspec M330 UV–Vis spectrometer (200–700 nm). The 
FTIR spectra (in 400-4000 cm-1 wavenumbers) were obtained using KBr disks on a Shimadzu 
FTIR model Prestige 21 spectrometer. Ultrasonic generation was carried out in an ultrasonic bath 
SONICA-2200 EP (frequency of 40 kHz). 
 
2.2. Solvothermal synthesis of DUT-32 crystals 
Single crystals of DUT-32 were prepared according to the previously reported solvothermal 
procedure [68]. 
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2.3. Synthesis of DUT-32 micro/nano-structures 
 Using various metal and ligands concentrations, DUT-32 micro/nano-structures were 
synthesized at ambient temperature and atmospheric pressure via irradiation in an ultrasonic bath 
for 30, 60, 90, and 120 minutes (Table 1). The products were then separated by centrifuge, 
washed  with DEF and then dried in air. 
 
Table 1. Experimental details for synthesis of DUT-32 micro/nano-structures. 
Samples 
name 
Time 
(min) 
Molar ratio (H3BTCTB: 
4,4´-BPDC: 
Zn(CH3COO)2.2H2O mmol) 
in 20 ml DEF 
Concentration [H3BTCTB]/[ 4,4´-
BPDC]/[ Zn(CH3COO)2.2H2O] 
(M) 
Frequency Modulator (3 ml) Morphology 
DUT-32-A 30 0.1:0.125:0.5 [0.005]/[0.006]/[0.025] 40 - Non-uniform particles 
DUT-32-B 60 0.1:0.125:0.5 [0.005]/[0.006]/[0.025] 40 - particles 
DUT-32-C 90 0.1:0.125:0.5 [0.005]/[0.006]/[0.025] 40 - Non-uniform micro/nano-
structures 
DUT-32-D 120 0.1:0.125:0.5 [0.005]/[0.006]/[0.025] 40 - Agglomerate structures 
DUT-32-E 60 0.3:0.125:0.5 [0.015]/[0.006]/[0.025] 40 - Agglomerate structures 
DUT-32-F 60 0.1:0.375:0.5 [0.005]/[0.018]/[0.025] 40 - Non-uniform needle 
DUT-32-G 60 0.3:0.375:0.5 [0.015]/[0.018]/[0.025] 40 - Non-uniform micro/nano-
structures 
DUT-32-H 60 0.3:0.375:1.5 [0.015]/[0.018]/[0.075] 40 - Agglomerate structures 
DUT-32-I 60 0.1:0.125:0.5 [0.005]/[0.006]/[0.025] 30 - Non-uniform micro/nano-
structures 
DUT-32-J 60 0.1:0.125:0.5 [0.005]/[0.006]/[0.025] 60 -  Layer by layer 
DUT-32-K 60 0.1:0.125:0.5 [0.005]/[0.006]/[0.025] 40 Pyridine Plates 
DUT-32-L 60 0.1:0.125:0.5 [0.005]/[0.006]/[0.025] 40 Acetic acid Spindles 
DUT-32-M 60 0.1:0.125:0.5 [0.005]/[0.006]/[0.025] 40 Acetic acid + Pyridine Non-uniform plates 
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2.4. Drug loading and in vitro drug release 
 The loaded samples adsorption with DOX was measured to estimate the amount of drug which 
can be loaded into the DUT-32 structure. The sample was dissolved in DMSO and 
spectrophotometry at 482 nm was performed. For determination of the drug concentration in 
solution, a calibration curve of free DOX content was established. The formulae below were 
used to obtain the drug loading content (DLC) and drug loading efficiency (DLE), (Eqs. 1 and 
2). 
		
		 =  				  ! 		"	#$!$	  ! %& 	× 100%                       +,. 1  
Drug	Loading	Ef:iciency	DLE = > amount	of	DOX	in	carrieramount	of	DOX	for	carrier	preparationD 		× 100%	+,. 2 
 
   In order to perform the release test in vitro, under atmospheric pressure, the DOX-loaded 
DUT-32-K was compacted into a disk (0.12 g, d = 7 mm), which was sealed into a dialysis bag 
(molecular cut off 50 kD). Under constant shaking, it was soaked in 200 mL of phosphate buffer 
solution (SBF at pHs equal to 7.4, 6, and 4.5) at 37 ℃. Then, in order to perform UV–Vis 
analysis, the doxorubicin-release medium was extracted at pre-determined time intervals. 
Finally, it was substituted with fresh SBF. 
 
2.5. Cell lines and in vitro toxicological study 
 In this work two cell lines, prostate cancer cell line (PC3) and cervical cancer cell line (HeLa), 
were selected and investigated to characterize the biocompatibility of the DUT-32-K 
micro/nano-structures as drug delivery systems in a test for in vitro toxicity. PC3 cell was 
cultured in RPMI-1640 medium supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% 
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(v/v) penicillin/streptomycin solution at 37 ℃ under a humidified atmosphere of 5% CO2. HeLa 
cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% 
(v/v) FBS and 1% (v/v) penicillin/streptomycin solution at 37 ℃ under a humidified atmosphere 
of 5% CO2. In order to examine the toxicity of the DUT-32-K micro/nano-structures, eight 
different concentrations were used and an MTT [3-(4,5-dimethylthiazol-2- yl)-2,5-
diphenyltetrazolium bromide] assay was carried out on the cell lines of PC3 and HeLa., Seeding 
of the cells in 96 well plates was performed at a density of 5100 per well, where the cells were 
left to adhere for 24 h. For 72 h, these cells were then incubated at eight different concentrations 
of DUT-32-K. After that, in a media with 0.5 mg mL-1 of MTT, the incubation was done at 37 ℃ 
for 3–4 h. In a MTT solubilizing buffer, the produced formazan crystals were dissolved. Using a 
microplate reader, the absorbance was calculated at 570 nm, and then a comparison was made 
between these values and those of the control cells. Meanwhile eight different concentrations of 
free DOX and DOX/DUT-32-K were used against PC3 and HeLa cells using the above 
mentioned procedure. 
 
2.6. Adsorption Equilibrium Studies 
 1 mg of adsorbent was used for each 50 ml of AMX solution (20 ppm) under stirring so that the 
assays of adsorption were carried out. Solid phase filtration was performed at defined intervals 
using centrifugation. UV–Vis spectroscopy was used to calculate the concentration of AMX 
remaining in the solution, Eq. 3 is used to allow calculation of the DUT-32-K absorption 
capacity. In order to determine the adsorption capacity, while the removal efficiency can be 
calculated by Eq. 4. 
F
GH	I	H	IJ = K − MNO 																																																																																											+,. 3 
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%QOR	S	TTIIJ = K − MK ∗ 100																																																																																				+,. 4 
Here, the initial and equilibrium liquid phase concentrations of AMX are given by Co (mg. L-1) 
and Ce (mg. L-1) respectively. Also, the total solution volume is shown by V(L), and m (g) 
stands for the adsorbent mass. 
 
3. Results and discussion 
   Morphology and size-controlled synthesis via sonochemical methods has already been used for 
a rapid and simple synthesis of DUT-32, C54H32O17N4Zn4×39.7 C5H11NO×11.3 H2O 
[Zn4O(BPDC)(BTCTB)4/3(DEF)39.7(H2O)11.3] on large scales. Using two symmetry-independent 
Zn4O6+ octahedral secondary building units, the DUT-32 structure is formed. These two units are 
coordinated to two BPDC2- and four BTCTB3- linkers. Ditopic ligands of BPDC2- have been set 
in a trans orientation in the first Zn4O6+ cluster; however, in the second cluster the linkers have a 
cis orientation in terms of one another. These links create a three-dimensional framework, in 
which three dissimilar but large mesopores (30 × 40 Å, 28 × 32 Å and 20 × 26 Å, assuming van 
der Waals radiuses of the atoms) as well as one smaller micropore (14 × 18 Å) can be observed 
(Figs. 1-3). There are two independent Zn/O inorganic clusters in the structure: The first lies on a 
general position and involves Zn1-Zn4 and O1, whereas the second cluster involves Zn5-Zn7 
and O2 and has a mirror plane running through Zn5, Zn7 and O2. The BPDC2- linkers join these 
two different inorganic clusters and possess an inversion center on the C5-C5 bond. There are 
two crystallographically independent environments for the BTCTB3- linkers: The first is coplanar 
with the same mirror which runs through the second inorganic cluster and has a 3-fold axis 
running normal to the center ring. The second BTCTB3- linker is intersected by the same mirror 
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plane, however this time it is normal to the plane of the linker, running through C79, C80, C83 
and N7. 
 
 
Fig. 1. (a) 3D extended structure of DUT-32, viewed down the b axis and with the Zn/O 
inorganic clusters drawn as polyhedrons, (b) a 3D simplified net of DUT-32 looking down the b 
axis, with pink as the metal centers, red as the BTCTB3- linkers and blue for the BPDC2- linkers, 
and (c) space-filling view of DUT-32 structure as viewed along a axis to show three-dimensional 
structure. All disordered guest molecules are omitted for clarity.  
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Fig. 2. Polyhedral representation of DUT-32 structure as viewed along the z axis to show three-
dimensional structure. 
 
 
Fig. 3. Perspective view of DUT-32 structure as viewed along the a axis to show three-
dimensional structure. 
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The solvothermal reaction of Zn(NO3)2.6H2O with H3BTCTB and the 4,4´-BPDC carboxylate 
ligand in the molar ratio of 5:1:1.25 at 100 ℃ and for 48 h, yielded white crystals of the DUT-32. 
On the other hand, under the ultrasonic illumination, micro/nano-structures of the DUT-32 
compound were achieved in the DEF solvent at ambient temperature in the minutes-hours 
timescale. Two different synthesis routes for the preparation of 
[Zn4O(BPDC)(BTCTB)4/3(DEF)39.7(H2O)11.3] are described in Fig. 4. 
 
 
Fig. 4. Schematic showing the synthetic routes to both single crystals and micro/nanostructured 
DUT-32. 
 
3.1.Sonication time 
 In the first step, viewed by field emission scanning electron microscopy (FE-SEM), the size and 
the shape of the sonochemically-synthesized DUT-32 micro/nano-structures were characterized 
by varying four parameters, namely: The time of sonication, initial reagent concentration, 
irradiation intensity, and help from modulators – as shown in Figs. 5 to 8. The preparation was 
carried out at four different sonication durations (samples of DUT-32-A to DUT-32-D) so as to 
explore the impacts of the time of sonication on DUT32 micro/nano-structures size and 
morphology. In this context, the optimal value of the sonication time was observed to be 60 min 
when the DUT-32-B nanostructures show increased regularity and uniformity in their size and 
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morphology (Fig. 5b). As the time of sonication was increased to 90 min and particularly when it 
was increased to 120 min (DUT-32-C and DUT-32-D), uniformity of the structures diminished 
and agglomerated forms were observed (Figs. 5c and d). When the time of sonication was 
reduced to 30 minutes (DUT-32-A), dissimilar sizes and irregular structures were resulted (DUT-
32-A). Therefore, the optimal time of sonication was considered to be 60 min, and the other 
factors influencing the DUT-32 micro/nano-structures final morphology were scrutinized. 
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Fig. 5. FE-SEM images of DUT-32 micro/nano-structures prepared through the sonochemical 
reaction with fixed reagent concentrations and fixed irradiation frequency in the absence of 
modulators at various times of sonication a) 30 min, b) 60 min, c) 90 min, and d) 120 min. 
 
3.2. Concentration of starting materials 
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 The aforesaid procedures were carried out with different reagent concentrations so that the 
impact of the initial reagent concentration on the nanostructured DUT-32 particle shape and size 
could be investigated (Fig. 6 a-d). To this end, four other experiments (DUT-32-E to DUT-32-H 
samples) were carried out. It was observed that the higher the concentration of the reagents, the 
less regular the shape of the resultant nanostructures and greater their mean diameter (Fig. 4). At 
lower reagent concentrations, the particles are more spherical, whereas at higher concentrations 
they adopt plate formations. However, in order to reduce the costs of the used materials and due 
to the importance of the nanostructure compounds, as already suggested in the introduction 
section, the lower initial concentrations were selected and studied as the optimal concentrations. 
In other words, the initial materials concentrations for DUT-32-B sample are here regarded as 
the optimum value. It was also found that the effect of increased concentration of the original 
reagents on the morphology and size of the said compounds are quite similar to the sonication 
time effect. In that there is an optimum value ([0.3:0.125:0.5]) where particle shape and size is 
uniform, but higher concentrations result in particle agglomeration. Also, it was observed that 
with the increased concentration and a longer time of reaction, the nanoparticles became 
agglomerated. Our obtained results were in close agreement with those in the literature [69]. It 
can be accounted for by the fact that nuclei growth is hindered by a rapid kinetics. Centers of 
nucleation are created in the bubbles and these centers have a limited growth due to the short 
collapse [70]. 
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Fig. 6. FE-SEM images of DUT-32 micro/nano-structures prepared by sonochemistry method 
having a 60-min sonication time under various molar ratios of the reagents [H3BTCTB:4,4´-
BPDC:Zn(CH3COO)2.2H2O]: a) [0.3:0.125:0.5], b) [0.1:0.375:0.5], c) [0.3:0.375:0.5], and d) 
[0.3:0.375:1.5]. 
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3.3. Effect of irradiation frequency 
 The irradiation time for DUT-32-I and DUT-32-J samples were fixed at 60 minutes, with fixed 
reagent concentration. DUT-32-I, irradiation frequency of 30 kHz, the plate-like structures 
agglomeration decreased, and size distribution was wider from nano to micro scales (for DUT-
32-B sample, however, the irradiation frequency increased to 40 kHz). Furthermore, when DUT-
32 irradiation frequency became greater (60 kHz for sample of DUT-32-J) than those of DUT-
32-I and DUT-32-B samples, an increase occurred in the nanostructures size and agglomeration 
(Fig. 7b). 
 
 
Fig. 7. FE-SEM images of DUT-32 micro/nano-structures produced by sonochemical process at 
fixed reagents concentrations with a 60-min time of sonication having different two irradiation 
intensities a) 30 kHz and b) 60 kHz. 
 
3.4. Effect of pyridine and acetic acid as modulator reagents 
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 In this work, ultrasonic irradiation has been coupled with the modulation method. The 
coordination equilibriums have been modulated using the ultrasound irradiation just by the 
addition of the pyridine an acetate ion modulators. These modulators have a chemical 
functionality similar to that of the linkers. When modulator reagents are employed, the 
coordination interaction between the organic linkers and the metal ions is inhibited, hence a 
competitive situation is created in which the crystal growth and framework extension rate is 
regulated. Samples DUT-32-K to DUT-32-M were synthesized under fixed reagent 
concentrations (0.1:0.125:0.5 molar ratios of H3BTCTB:4,4´-BPDC:Zn(CH3COO)2.2H2O 
respectively), irradiation frequency (40 kHz) and duration (60 minutes), and modulator volume 
(3ml). The type of modulator used in the syntheses was varied across samples DUT-32-K to 
DUT-32-M, using pyridine, acetic acid, and a 50:50, v:v mixture respectively. From looking at 
the FE-SEM images (Fig. 8), it was found that pyridine produced the particles with the most 
uniform size and shape, followed by acetic acid, and finally the mixture which gave much larger 
non-uniform particles. In other words, results showed that although the main morphology has not 
changed, the presence of pure pyridine has led to the synthesis of the new plate-like 
morphologies in DUT-32-K sample. Under close scrutiny, the particles produced by the pyridine 
modulator show new plate-like morphologies, along with directional growth and smaller 
thicknesses. In this context, we have made use of our three synthesized samples (i.e. DUT-32-B, 
DUT-32-K, and DUT-32-L micro/nano-structures) as models in our applications so that better 
results can be provided under these optimized conditions. It can be concluded therefore, that the 
size and morphology of the MOF nanostructure is dependent on all four synthetic variables that 
we investigated, highlighting that it is important to optimize these conditions when synthesizing 
any new MOF via this method. 
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Fig. 8. FE-SEM images of DUT-32 micro/nano-structures prepared by sonochemical process 
where reagents concentrations are constant using a 40-W irradiation frequency in a 60-min time 
of sonication in the presence of two dissimilar modulators (3 ml): a) pyridine, b) acetic acid, and 
c) acetic acid + pyridine. 
 
  
22 
 
   When the experimental results of the sonochemical process and the simulation results are 
compared using their powder X-ray diffraction (PXRD) patterns, it is corroborated that the 
sonochemically synthesized DUT-32 yields the same structure as the DUT-32 sample 
synthesized by conventional heating – as shown in Fig. 9.  
 
 
Fig. 9. PXRD patterns of DUT-32 micro/nano-structures, prepared by either conventional 
heating or sonochemical reaction: a) simulated DUT-32, b) DUT-32 conventional heating, and c) 
DUT-32-K nanoplates. 
 
   Fig. 10 compares the DUT-32-K nanostructures synthesized through the sonochemical process 
with the bulk material prepared by the solvothermal approach, and H3BTCTB and 4,4´-BPDC 
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ligands in terms of their IR spectra. For the 4,4´-BPDC and H3BTCTB ligands in the DUT-32 
sample, characteristic adsorption bands are observed: Corresponding to DMF carbonyl group as 
the molecular guest some absorption bands with variable intensities are seen between 1340-1630 
cm-1. Corresponding to uncoordinated carboxylate of fumarate, absorption bands are observed at 
1735 cm-1 [71]. FT-IR analyses have also been performed for samples of DUT-32 single crystals 
and DUT-32-K nanostructures. In all these two samples there are sharp peaks of 4,4´-BPDC and 
H3BTCTB ligands between 1200 to 1600 cm-1, which demonstrates that the two ligands are 
present in the DUT-32 structure. 
 
 
Fig. 10. Comparison of FTIR spectra of 4,4´-BPDC ligand (a), H3BTCTB ligand (b),  DUT-32 
crystals (c), and DUT-32-K nanostructures (d) which is synthesized by solvothermal method, and 
morphology modified. 
 
   Fig. 11 the diagram of N2 adsorption-desorption isotherm for DUT-32-K micro/nano-structures 
is shown. The trend is in agreement with that of mesoporous materials in the literature. Table 2 
makes a comparison between this diagram and the BET surface area for the other samples in this 
study. According to the table, DUT-32-K exhibits the highest BET surface area and Drug loading 
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efficiency. In DUT-32-B micro/nano-structures, the amounts of the adsorbed N2 and BET 
surface area are lower than those in sample of DUT-32-L and DUT-32 crystals. Apparently, 
when the modulator reagent is present during synthesis, the BET surface area of the DUT-32 
compound is no longer negatively affected by the reduction in the size of the particles. Indeed, 
the totally flat branches of absorption are observed up to p/p = 0.9 as the porosity occurrence is 
disregarded. In this context, mesoporous materials are thus synthesized. As a result of the cage-
shaped pores created from defects, a hysteric loop is likely to develop. According to literature, 
the synthesis route impact on the MOF porosity can be ascribed to the formation of structural 
defects [72, 73]. It follows then, that DUT-32-K must have larger/more defects than DUT-32-B 
and DUT-32-L, as a result of the modulator present during its synthesis. Consequently, based on 
the N2 adsorption isotherm for the best sonochemically synthesized morphology (i.e. DUT-32-
K), a slight improvement is observed for the BET surface area (4876 m2/g) in comparison with 
prepared sample via hydrothermal and DUT-32-B and DUT-32-L micro/nano-structures 
synthesized via ultrasonic irradiation. Even so, a considerable challenge still exists as to explain 
how the shape, porosity, and especially the dispersion of the small mesoporous particles can be 
fully controlled [74-76]. 
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Fig. 11. N2 adsorption-desorption isotherm collected at 77 K for DUT-32-K micro/nano-
structures synthesized via ultrasonic irradiation in the presence of pyridine as a modulator. 
 
Table 2 
Drug loading content and drug loading efficiency of the DUT-32 samples. 
Samples Surface area Drug loading content Drug loading efficiency 
DUT-32 crystals 4376 11.76 17.54 
DUT-32-B 4107 9.73 15.32 
DUT-32-K 4876 18.45 25.18 
DUT-32-L 4522 14.08 20.95 
 
   Figs. 12 and 13 investigate the AMX removal efficiency of the same four DUT-32 samples 
placed in aqueous 20 ppm AMX solution for 120 min. 92% removal efficiency was observed 
after 120 min in the presence of the single crystals of DUT-32. This means that by use of the 
sonochemical synthesis methods nanoplates can be produced which remove more AMX from 
solution and faster than the single crystals, produced by the traditional hydrothermal synthesis 
method. 
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Fig. 12. Removal efficiency of AMX by four different DUT-32 samples, assessed using UV–Vis 
absorption spectroscopy. 
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Fig. 13. UV–Vis absorption spectra of a solution of 20 ppm AMX in presence of (a) DUT-32 
crystals, b) DUT-32-B, c) DUT-32-K, and d) DUT-32-L. 
 
   In the present study, the AMX removal kinetics in the suspended solutions, with DUT-32-K as 
the superior absorbent, has been investigated utilizing the kinetics of zero, first, and second order 
rate reactions – as shown in Fig. 14 and Table 3. Using this kinetics relation, as shown in Table 
3, different correlation coefficients have been estimated. In this relation, the correlation 
coefficients of zero, first and second order rate equations are represented by R0, R1, and R2, 
respectively. R1 shows superior correlation with K1 = 0.0281 min-1 with regard to the DUT-32-K 
nanostructures. In this context, it can be posited that first order reaction kinetics is conditioned 
by the removal of AMX from the MOF. 
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Fig. 14. Reaction kinetics of AMX removal for DUT-32-K micro/nano-structures, (a) zero (b) 
first and (c) second order. 
Table 3 
Kinetics parameters for different kinetic models for AMX removal using four different samples. 
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Samples R0 R1 R2 Order(s) K1 (min-1) 
DUT-32 crystal 0.9454 0.9825 0.7839 y = 0.0268x - 0.2759 0.0268 
DUT-32-B 0.9217 0.9677 0.7757 y = 0.0203x - 0.2463 0.0203 
DUT-32-K 0.9399 0.9758 0.7694 y = 0.0281x - 0.2828 0.0281 
DUT-32-L 0.9240 0.9583 0.7041 y = 0.0231x - 0.2609 0.0231 
 
3.5. Doxorubicin hydrochloride loading and release 
 DOX, a typical anti-cancer drug, was introduced into DUT-32 to evaluate the loading and 
sustained release behaviors. According to the results (Table 2), the maximum DOX drug loading 
is achieved by DUT-32-K, which could be explained again by the increase in the DUT-32-K 
BET surface area, brought about by the structural defects introduced by the modulator. This 
surface area to drug loading capacity relationship is shown again by DUT-32-B possessing the 
smallest surface area and loading capacity. As reported in the literature, drug loading and drug 
release are both influenced by the various forces such as Van der Waals, coordination bonds, 
hydrogen bonds, electrostatic interactions and pi-pi interactions. Of these, electrostatic interactions 
are reported to have the most significant effect [77]. 
   For ensuring that the system output in the physiological environment is in fact the drug, the 
release profile is analysed. The DOX release behavior at pH 7.4 and physiological temperature 
vs time for the four DUT-32 samples is shown in Fig. 15.  The percentage of released guest 
molecules is calculated from data obtained using UV–Vis spectrophotometry (Fig. 16). As the 
time passes, a gradual growth in DOX concentration occurs, showing that DOX molecules are 
continuously released. Once again, the optimized DUT-32-K performed the best, releasing 54% 
of the DOX in 100 hours. A two-phase drug release behavior was observed, with a low initial 
burst release (within 24% of the loaded value) in 30 hours. The breaking of weaker drug-MOF 
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interactions on the DUT-32 exterior surface are responsible for the preliminary rapid release rate 
in 0-30 h. The guest drug molecules held in the interior pores are responsible for the sustained 
release of DOX with a decreased rate of release from 30 h to 100 h.  
 
 
Fig. 15. The cumulative drug release of DOX from the four DUT-32 samples at pH of 7.4 and 
physiological temperature. 
 
Fig. 16 shows a sorption band at 482 nm, which increases in intensity with lengthening of the 
release time due to DOX molecules cumulative release over time, demonstrating that 
nano/micro-DUT-32 is able to maintain the integrity of its crystalline structure at these 
conditions.  
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Fig. 16.  UV/Vis absorption spectra of the DOX release through carriers of DUT-32-K (a), DUT-
32-L (b), DUT-32 crystal (c), and DUT-32-B (d) at pH of 7.4 and physiological temperature. 
 
  A kinetic model of drug release can be provided (Fig. 17), as DUT-32 maintains the integrity of 
its framework in these test conditions. Progressive desorption from the pores is responsible for 
DOX release, so in accordance with the Fick diffusion law, the fitted data can be expressed 
through the single exponential function below (Eq. 5):  
Ln (1-Mt/M∞) ＝ -kt                                                                                                                (Eq. 5) 
Here, release value at time t is shown by Mt, M∞ signifies the maximum release, and k represents 
the first order release constant. Results of the fitted data demonstrate that the release constant K 
= 0.227 h-1 while R2 = 0.9925. 
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Fig. 17. Kinetic model of drug release of DOX from DOX/DUT-32-K plotted against time, in 
SBF solution and physiological temperature. 
 
  Decreasing the pH increases the rate of DOX released from DUT-32-K, indicating its 
dependency on pH. In this range of pH, drug release and change from physiological pH to lower, 
acidic pHs are described. Cancerous cells are slightly acidic with pH values of 4-6. Therefore, in 
a desired system of drug delivery, drug molecules ought to be released in this range of pH. 
MOFs are commonly stable at neutral pH, but in the acidic range, dissociation of the framework 
occurs as a result of ligand-metal ionic coordination becoming separated. Resultantly, at this 
acidic pH, an opportunity arises for the drug release. Fig. 18 a-c shows a constant growth in the 
intensity of UV–Vis spectra at 482 nm by the passing of time, thus indicating the molecular drug 
release from the framework of DUT-32. Because of DUT-32-K stability at pH 7.4, the drug 
release is very low and the intensity of UV–Vis spectra does not show any significant increase. 
This is an important observation as healthy cells pH is approximately 7.4, the MOF framework 
remains intact and a reduced drug release is observed. With the passage of 4 days, by pH 
variations from 7.4, 6, and 4.5 at 37 ℃, the final release rate of DOX might increase up to 54%, 
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83%, and 98%, respectively, which is perhaps due to ligands protonation by decreased pH. This 
in turn causes the electrostatic interaction between DUT-32-K functional groups and DOX to be 
dissociated. Resultantly, the incorporated DOX Is no longer held in place by a well structurally 
ordered MOF and is released from the samples. Both drug loading and drug release mechanisms 
and rates are affected by the carriers in drug delivery systems. Hence, great importance is 
attached to the provision of effective and inexpensive carriers in drug delivery systems, 
especially for practical pharmaceutical applications.  
 
 
Fig. 18. Representative UV–Vis spectra of the release buffer of DUT-32-K micro/nano-
structures with increasing time at pH = 7.4 (a), pH = 6 (b), and pH = 4.5 (c); cumulative DOX 
release (%) from DOX/DUT-32-K carrier at three different pHs (d). 
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   FTIR spectra of the free DOX and the synthesized products are given in Fig. 19. A broad band 
around 3450 cm-1 can be observed, which is caused by the O–H stretching from the molecules of 
water [78, 79]. The band’s broadness is in accord with the extensive hydrogen bonding of the 
non-coordinated and coordinated molecules of water [80]. The asymmetric and symmetric 
(OCO-) stretching from the carboxylate groups are responsible for the observed bands at 1647 
cm-1 and 1387 cm-1. Because of the C=C stretching from the aromatic rings, a further band at 
1597 is observed. The successful loading of DOX onto the surface of DUT-32-K was also 
proved by FTIR spectra (Fig. 19c) and the IR bands of DOX/DUT-32-K revealed characteristic 
modes of the DOX molecules: Firstly, the absorption bands of the C=C skeleton vibration at 
1615 cm-1 and C–H out-of-plane bending vibration at 796 cm-1 correspond to the aromatic rings 
of DOX. The band observed at 1735 cm-1 is assigned to the C=O stretching of aldehydes group 
whereas the band at 1709 cm-1 corresponds to the C=O stretching of unsaturated esters. The band 
at 1064 cm-1 and 1104 cm-1 corresponds to the C–N stretching of aliphatic amines. Also, the N–
H stretching band at 3320 cm-1 of free DOX, shifted to 3343 cm-1 in case of DOX/DUT-32-K. In 
addition, the adsorption of DOX onto DUT-32-K surfaces was distinctive, as evidenced by a 
larger peak at 1594 cm-1, assigned to the C=O bond at the 13-keto position of DOX [81]. 
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Fig. 19. Comparison of IR spectra of free DOX (a), DUT-32-K nanostructures (b), and 
DOX/DUT-32-K (c). 
 
   The adsorption process results from the interaction between the guest molecule and the 
adsorbent material, in our case, the DUT-32 and DOX. Generally, these MOF-drug interactions 
are weak physisorption interactions. However, in some cases, the interactions between the host 
and the guest molecules are strong, and resultantly structural changes and chemisorption and are 
likely to happen. Accordingly, a viable tool for the study of such crystalline transformations will 
be the PXRD. The experimental powder pattern of DUT-32-K in DOX is shown by the red line 
in Fig. 20. Expectedly, all of the peaks which are associated with the 
[Zn4O(BPDC)(BTCTB)4/3(DEF)39.7(H2O)11.3] structure prepared by Kaske et al. are shown in  
this diffractogram [68]. In Fig. 20, PXRD data for the DUT-32-K sample are shown in green 
color. In spite of the still retaining strong crystallinity, a structural variation in DUT-32 can be 
observed during the incorporation process, which is likely to be caused by the supra-molecular 
interactions of the MOF and the drug. The intense signals at 2θ values of 25.96, 14.08, and 9.82 
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which are related to the miller indices [220], [002], and [102] respectively in DOX, which 
confirms the drugs incorporation into the DUT-32 structure. This finding is in agreement with 
the results in the literature [82] and with the IR-spectroscopy results. When the test of dissolution 
is completed, the release of the incorporated DOX occurs. Afterwards, as shown in Fig. 20c in 
blue, the powder pattern is collected. As we have expected, no diffraction peaks corresponding to 
the drug were observed. This observation fits with the results of the dissolution test. Similarly, 
the structural variations of the DUT-32-K have here been detected, where a slight amorphization 
has been seen in the structure. 
 
 
Fig. 20. XRD patterns of DUT-32-K micro/nano-structures before release test (green line) 
DOX/DUT-32-K (red line), and DUT-32-K micro/nano-structures after release test (blue line). 
 
3.6.In vitro cytotoxicity 
 After the drug molecules of DOX are encapsulated into DUT-32-K frameworks, both DUT-32-
K and drug-loaded DUT-32-K (i.e. DOX/DUT-32-K) were explored in terms of their 
biocompatibility. Using MTT assays, the cytotoxic effects of DOX/DUT-32-K and free DOX 
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were compared. According to Fig. 21, as the concentrations of DOX/DUT-32-K and free DOX 
increase from 0.3125 to 40 µg ml-1, so do their cytotoxic effects on prostate cancer cell line 
(PC3) and cervical cancer cell line (HeLa). Under a shared 24-hour culture, the DOX/DUT-32-K 
is observed to cause PC3 and HeLa cells death analogous to the free DOX. With their shared 
culture for 72 h, in all concentrations with the exception of 0.3125 µg ml-1, DOX/DUT-32-K 
demonstrates more cytotoxic effects than free DOX. This increase in DOX/DUT-32-K 
cytotoxicity, compared to free DOX, is primarily caused by the constant release of the molecular 
drug from the MOF frameworks as well as the enhanced DOX uptake by the loaded cells in 
DUT-32-K frameworks. Furthermore, the intact DUT-32-K micro/nano-structures 
biocompatibility has been investigated. Different DUT-32-K concentrations have been incubated 
for 24 h and 72 h with PC3 and HeLa cells, and assessment of the cells viability has then been 
performed. In the tested range of concentrations and even as it rises to 40 µg ml-1, biocompatible 
DUT-32-K micro/nano-structures does not show any drastic effects upon the viability of the 
cells, and thus it can be posited that DUT-32-K has no cytotoxic impact – as shown in Fig. 21. 
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Fig. 21. Comparison of the cytotoxic effects of DUT-32-K, DOX/DUT-32-K, and free DOX on 
cells viability evaluated by incubating various concentrations of samples for 24 h and 72 h with 
HeLa cells (a and b) and PC-3 cells (c and d). 
 
4. Conclusion 
In this study, regular nanoplates of the MOF DUT-32 were prepared through the use of 
sonication and a pyridine modulator. During the optimization process, it was found that 
sonication time, reagent concentration, irradiation frequency and modulator 
composition/concentration all effected the shape, size and morphology of the nanostructures 
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formed. It was also found that the nanostructures formed with the most regular size and 
morphology also possessed the highest BET surface area, likely as a result of the modulator 
creating additional/larger internal defects. This more regular particle size and/or larger surface 
area also lead the optimized sample (DUT-32-K) to have the highest AMX absorption and most 
favorable DOX release behavior. Not only was the MOF shown to hold its structure at 
physiological conditions, but it was shown to increase its release efficiency from 54% to 98% 
(after 100 hours) in pHs 7.4 to 4.5 respectively. Furthermore, the DOX loaded DUT-32-K was 
shown to kill cancerous cells just as efficiently as free DOX and the DUT-32-K alone was shown 
in a viability study to have a low cytotoxicity to healthy cells. These results show that not only 
are these DUT-32-K nanostructures capable of efficient drug loading and of a tumor specific 
release, but are also able to mop up environmentally harmful POPs (AMX) from water sources, 
where they are ubiquitous. 
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